Equities

Amedisys Inc

Amedisys Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,2362,2232,214
OPERATING EXPENSES
Cost of revenue total1,2461,2511,199
Selling, general and admin. expenses, total780754711
Depreciation/amortization182531
Unusual expense(income)1431221
Other operating expenses, total------
Total operating expense2,1862,0421,962
Operating income50181252
Other, net6.471.571.75
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes40160280
Provision for income taxes514370
Net income after taxes(11)118210
Minority interest1.190.91(1.09)
Net income before extra. Items(9.75)119209
Total extraordinary items------
Net income(9.75)119209
Inc.avail. to common excl. extra. Items(9.75)119209
Inc.avail. to common incl. extra. Items(9.75)119209
EPS RECONCILIATION
Basic/primary weighted average shares333333
Basic/primary eps excl. extra items(0.3)3.656.41
Basic/primary eps incl. extra items(0.3)3.656.41
Dilution adjustment------
Diluted weighted average shares333333
Diluted eps excl. extra items(0.3)3.636.34
Diluted eps incl. extra items(0.3)3.636.34
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental31229.53
SUPPLEMENTAL INCOME
Depreciation, supplemental181212
Total special items1431522
NORMALISED INCOME
Normalized income before taxes182175302
Effect of special items on income taxes503.885.44
Income tax excluding impact of special items1014676
Normalized income after tax82128226
Normalized income avail. to common83129225
Basic normalized EPS2.553.986.91
Diluted normalized EPS2.553.966.84
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.